KYNAM CAPITAL MANAGEMENT, LP
Adviser information for KYNAM CAPITAL MANAGEMENT, LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Partnership |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 3 |
|---|---|
| Investment Advisory/Research | 2 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | Yes |
|---|
| Type | Accounts | RAUM |
|---|---|---|
| Discretionary | 5 | $1.8B |
| Non-Discretionary | 0 | $0 |
| Total | 5 | $1.8B |
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 5 | $1.8B |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 80 |
Services
| Advisory Services | Portfolio management for pooled investment vehicles |
|---|---|
| Compensation | % of AUMPerformance-based fees |
| Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
221 ELM ROADPRINCETON
NJ
United States
Monday - Friday, 9AM - 5PM
Tel: 574-315-9016, Fax: None
Chief Compliance Officer
JARED KELLER
CHIEF COMPLIANCE OFFICER
221 ELM ROAD
PRINCETON
NJ
United States
Tel:
646-753-2832
J*@***********M
(Full email address available in API data)
Regulatory Contact
YUE TANG
MANAGING MEMBER
221 ELM ROAD
PRINCETON
NJ
United States
Tel:
574-315-9016
D*@***********M
(Full email address available in API data)
Industry Affiliates
| KYNAM FUND GP, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| KYNAM GLOBAL HEALTHCARE MASTER FUND, LP | Hedge Fund | $1,578.5M | $10.0M | 88 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| KELLER, JARED, J | Individual | – | CHIEF OPERATING OFFICER, CHIEF COMPLIANCE OFFICER | 03/2024 | < 5% |
| TANG, YUE | Individual | – | MANAGING MEMBER | 10/2020 | > 75% |
| KYNAM CAPITAL MANAGEMENT GP, LLC | Domestic Entity | – | GENERAL PARTNER | 10/2020 | < 5% |
| TANG, YUE | Individual | KYNAM CAPITAL MANAGEMENT GP, LLC | MANAGING MEMBER | 10/2020 | > 75% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| 2SEVENTY BIO INC | COMMON STOCK | 23M | 6M | – |
| ACELYRIN INC | COM | 4M | 831K | – |
| ALNYLAM PHARMACEUTICALS INC | COM | 10M | 43K | – |
| AMARIN CORP PLC | SPONS ADR NEW | 8M | 12M | – |
| BIOCRYST PHARMACEUTICALS INC | COM | 55M | 9M | – |
| BURNING ROCK BIOTECH LTD | SPONSORED ADS | 6M | 975K | – |
| CARIBOU BIOSCIENCES INC | COM | 3M | 2M | – |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 125M | 3M | – |
| CG ONCOLOGY INC | COM | 2M | 54K | – |
| COGENT BIOSCIENCES INC | COM | 78M | 9M | – |
| DYNAVAX TECHNOLOGIES CORP | COM NEW | 80M | 7M | – |
| INSMED INC | COM PAR $.01 | 67M | 1M | – |
| IRONWOOD PHARMACEUTICALS INC | COM CL A | 11M | 2M | – |
| LIQUIDIA CORPORATION | COM NEW | 11M | 917K | – |
| NATERA INC | COM | 218M | 2M | – |
| PROTAGONIST THERAPEUTICS INC | COM | 28M | 800K | – |
| SPDR S&P 500 ETF TR | TR UNIT | 109M | 200K | – |
| SUTRO BIOPHARMA INC | COM | 6M | 2M | – |
| SYNDAX PHARMACEUTICALS INC | COM | 117M | 6M | – |
| TRAVERE THERAPEUTICS INC | COM | 17M | 2M | – |
| TYRA BIOSCIENCES INC | COM | 9M | 567K | – |
| VAXCYTE INC | COM | 57M | 753K | – |
| VERA THERAPEUTICS INC | CL A | 56M | 2M | – |
| VERTEX PHARMACEUTICALS INC | COM | 155M | 330K | – |
| VIRIDIAN THERAPEUTICS INC | COM | 23M | 2M | – |
| WAVE LIFE SCIENCES LTD | SHS | 20M | 4M | – |